Retracted: Analysis of Data on Fludarabine, Cyclophosphamide, and Rituximab Chemoimmunotherapy for Chronic Lymphocytic Leukemia Shows High Patient Heterogeneity and the Need for More Consideration of Individualized Treatment
Comput Math Methods Med. 2023 Dec 13:2023:9758345.
doi: 10.1155/2023/9758345.
eCollection 2023.